Research output per year
Research output per year
Fingerprint
Dive into the research topics where Harald E. Vonkeman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Early radiological progression remains associated with long-term joint damage in real-world rheumatoid arthritis patients treated to the target of remission
Versteeg, G. A., Steunebrink, L. M. M., Vonkeman, H. E., Ten Klooster, P. M., Van Der Bijl, A. E. & Van De Laar, M. A. F. J., 21 Jun 2021, (E-pub ahead of print/First online) In: Scandinavian journal of rheumatology.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
Performance of three composite measures for disease activity in peripheral spondyloarthritis
Beckers, E., Been, M., Webers, C., Boonen, A., Klooster, P. M. T., Vonkeman, H. E. & van Tubergen, A., 1 Sep 2021, (Accepted/In press) In: Journal of rheumatology. 19 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Treat-to-target in axial spondyloarthritis: an observational study in daily practice
Beckers, E., Boonen, A., Webers, C., ten Klooster, P., Vonkeman, H., Efdé, M. & van Tubergen, A., 27 Jun 2021, In: Rheumatology. 21 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Frequency of real-world reported adverse drug reactions in rheumatoid arthritis patients
Giraud, E. L., Jessurun, N. T., van Hunsel, F. P. A. M., van Puijenbroek, E. P., van Tubergen, A., Ten Klooster, P. M. & Vonkeman, H. E., Dec 2020, In: Expert opinion on drug safety. 19, 12, p. 1617-1624 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile3 Citations (Scopus)33 Downloads (Pure) -
Immune-mediated inflammatory disease patients’ preferences in adverse drug reaction information regarding biologics
Kosse, L. J., Weits, G., Vonkeman, H. E., Spuls, P. I., Van Den Bemt, B. J. F., Tas, S. W., Hoentjen, F., Nurmohamed, M. T., Van Doorn, M. B. A., Van Puijenbroek, E. P. & Jessurun, N. T., 2020, In: Expert opinion on drug safety. 19, 8, p. 1049-1054 6 p.Research output: Contribution to journal › Article › Academic › peer-review
1 Citation (Scopus)
Activities
- 7 Oral presentation
-
Blended interventions for personalized health: is this the way patients and professionals like to go?
Christina Bode (Speaker), Erik Taal (Contributor), Harald Erwin Vonkeman (Contributor), Fatima Ben Allouch (Contributor) & Katharina Hohl (Contributor)
2 Feb 2017Activity: Talk or presentation › Oral presentation
-
Impact of patient-accessible Electronic Medical Records in rheumatology: use, satisfaction and effects on empowerment
Rosalie van der Vaart (Speaker), Stans C.H.C. Drossaert (Speaker), Erik Taal (Speaker), Harald E. Vonkeman (Speaker) & Mart A.F.J. van de Laar (Speaker)
28 Sep 2014 → 1 Oct 2014Activity: Talk or presentation › Oral presentation
-
Impact of patient-accessible Electronic Medical Records in rheumatology: use, satisfaction and effects on empowerment
Rosalie van der Vaart (Speaker), Constance H.C. Drossaert (Speaker), Erik Taal (Speaker), Harald E. Vonkeman (Speaker), K.W. Drossaers-Bakker (Speaker) & Mart A.F.J. van de Laar (Speaker)
28 Sep 2014Activity: Talk or presentation › Oral presentation
-
Predicting non-improved subjective health in rheumatiod arthritis patients with a clinical response to biologic treatment
Antonius H. Oude Voshaar (Speaker), Erik Taal (Speaker), Peter M. ten Klooster (Speaker), Harald Erwin Vonkeman (Speaker) & Mart A F J van de Laar (Speaker)
6 Feb 2014Activity: Talk or presentation › Oral presentation
-
Fatigue in RA patients with low disease activity
Lonneke I.M. Lenferink (Speaker), Christina Bode (Speaker), Stephanie Nikolaus (Speaker) & Harald E. Vonkeman (Speaker)
2014Activity: Talk or presentation › Oral presentation